Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.009 |